Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Combination of olfactory test and substantia nigra transcranial sonopraphy in the differential diagnosis of Parkinson's disease: a pilot study from China.

Chen W, Tan YY, Hu YY, Zhan WW, Wu L, Lou Y, Wang X, Zhou Y, Huang P, Gao Y, Xiao Q, Chen SD.

Transl Neurodegener. 2012 Dec 26;1(1):25. doi: 10.1186/2047-9158-1-25.

2.

Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease.

López Hernández N, García Escrivá A, Shalabi Benavent M.

Neurologia. 2015 Oct;30(8):496-501. doi: 10.1016/j.nrl.2014.03.010. Epub 2014 May 17. English, Spanish.

3.

Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease.

Busse K, Heilmann R, Kleinschmidt S, Abu-Mugheisib M, Höppner J, Wunderlich C, Gemende I, Kaulitz L, Wolters A, Benecke R, Walter U.

J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):441-7. doi: 10.1136/jnnp-2011-301719. Epub 2012 Feb 22.

PMID:
22362921
4.

Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.

Izawa MO, Miwa H, Kajimoto Y, Kondo T.

Eur J Neurol. 2012 Mar;19(3):411-6. doi: 10.1111/j.1468-1331.2011.03533.x. Epub 2011 Oct 7.

PMID:
21978091
5.

A population-based study on combined markers for early Parkinson's disease.

Tunc S, Graf J, Tadic V, Brüggemann N, Schmidt A, Al-Khaled M, Wolff S, Vollstedt EJ, Lorwin A, Hampf J, Piskol L, Klein C, Hagenah J, Kasten M.

Mov Disord. 2015 Apr;30(4):531-7. doi: 10.1002/mds.26100. Epub 2014 Dec 27.

PMID:
25546094
6.

Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly.

Berg D, Seppi K, Liepelt I, Schweitzer K, Wollenweber F, Wolf B, Dillmann U, Stockner H, Godau J, Kiechl S, Gaenslen A, Willeit J, Di Santo A, Maetzler W, Gasser T, Poewe W, Behnke S.

Mov Disord. 2010 Jul 30;25(10):1464-9. doi: 10.1002/mds.23114.

PMID:
20629151
7.
8.

Transcranial sonography on Parkinson's disease and essential tremor.

Chitsaz A, Mehrbod N, Saadatnia M, Fereidan-Esfahani M, Akbari M, Abtahi SH.

J Res Med Sci. 2013 Mar;18(Suppl 1):S28-31.

9.

Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations.

Okawa M, Miwa H, Kajimoto Y, Hama K, Morita S, Nakanishi I, Kondo T.

Intern Med. 2007;46(18):1527-31. Epub 2007 Sep 14.

10.

Transcranial sonography in essential tremor.

Stockner H, Wurster I.

Int Rev Neurobiol. 2010;90:189-97. doi: 10.1016/S0074-7742(10)90014-7. Review.

PMID:
20692503
11.

Substantia nigra hyperechogenicity in Polish patients with Parkinson's disease.

Ambrosius W, Michalak S, Owecki M, Łukasik M, Florczak-Wyspiańska J, Kozubski W.

Folia Morphol (Warsz). 2014 Aug;73(3):267-71. doi: 10.5603/FM.2014.0042.

PMID:
25706660
12.

Validation of a new scale to assess olfactory dysfunction in patients with Parkinson's disease.

Millar Vernetti P, Perez Lloret S, Rossi M, Cerquetti D, Merello M.

Parkinsonism Relat Disord. 2012 May;18(4):358-61. doi: 10.1016/j.parkreldis.2011.12.001. Epub 2012 Jan 5.

PMID:
22227345
13.

Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.

Berg D.

J Neural Transm (Vienna). 2011 Apr;118(4):613-9. doi: 10.1007/s00702-010-0565-6. Epub 2011 Jan 5. Review.

PMID:
21207077
14.

Predictors for mild parkinsonian signs: a prospective population-based study.

Mahlknecht P, Kiechl S, Stockner H, Willeit J, Gasperi A, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2015 Mar;21(3):321-4. doi: 10.1016/j.parkreldis.2014.12.021. Epub 2014 Dec 31.

PMID:
25585991
15.

Distinguishing Parkinson's disease and essential tremor with transcranial sonography.

Budisic M, Trkanjec Z, Bosnjak J, Lovrencic-Huzjan A, Vukovic V, Demarin V.

Acta Neurol Scand. 2009 Jan;119(1):17-21. doi: 10.1111/j.1600-0404.2008.01056.x. Epub 2008 Jun 10. Review.

PMID:
18549415
16.

Accuracy of transcranial brain parenchyma sonography in the diagnosis of dementia with Lewy bodies.

Favaretto S, Walter U, Baracchini C, Pompanin S, Bussè C, Zorzi G, Ermani M, Cagnin A.

Eur J Neurol. 2016 Aug;23(8):1322-8. doi: 10.1111/ene.13028. Epub 2016 May 1.

PMID:
27132982
17.

Early diagnosis of Parkinson's disease.

Gaenslen A, Berg D.

Int Rev Neurobiol. 2010;90:81-92. doi: 10.1016/S0074-7742(10)90006-8. Review.

PMID:
20692495
18.

The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson's disease: comparison with DAT PET scans.

Liu P, Li X, Li FF, Ou-Yang QH, Zhang HX, Feng T.

Neurosci Lett. 2014 Oct 17;582:99-103. doi: 10.1016/j.neulet.2014.08.053. Epub 2014 Sep 10.

PMID:
25218716
19.

Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.

Mahlknecht P, Seppi K, Stockner H, Nocker M, Scherfler C, Kiechl S, Willeit J, Schmidauer C, Gasperi A, Rungger G, Poewe W.

Neurodegener Dis. 2013;12(4):212-8. doi: 10.1159/000348595. Epub 2013 May 18.

PMID:
23689066
20.

Relevance of substantia nigra hyperechogenicity and reduced odor identification in idiopathic REM sleep behavior disorder.

Iwanami M, Miyamoto T, Miyamoto M, Hirata K, Takada E.

Sleep Med. 2010 Apr;11(4):361-5. doi: 10.1016/j.sleep.2009.12.006.

PMID:
20223708

Supplemental Content

Support Center